Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for September 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
News Media Under-Report Drug Company Funding of Research
TUESDAY, Sept. 30 (HealthDay News) -- Reports on medication research published in general news media often fail to disclose that the research received pharmaceutical company funding and frequently refer to drugs by brand name rather than using the generic name, according to an article published in the Oct. 1 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Bisphosphonate Infusion Linked to Ocular Complication
WEDNESDAY, Sept. 24 (HealthDay News) -- Physicians should be aware that bisphosphonate infusions can result in a serious but rare complication: orbital inflammatory disease, according to a case study published in the Sept. 25 issue of the New England Journal of Medicine.
Abstract
Full Text
No Change to 2009 Part B Medicare Premium
MONDAY, Sept. 22 (HealthDay News) -- There will be no change to the Part B Standard Medicare premium in 2009 compared with 2008. This is the first time since 2000 that the premium has not risen over the prior year, according to an announcement by the Department of Health and Human Services' Centers for Medicare & Medicaid Services (CMS).
More Information
Childhood Paracetamol Use Linked to Later Asthma Symptoms
FRIDAY, Sept. 19 (HealthDay News) -- The use of paracetamol (acetaminophen), whether in the first year of life or later in childhood, is associated with higher risk of asthma symptoms at ages 6 and 7, according to research published in the Sept. 20 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Measuring Exhaled NO Adds Little to Asthma Treatment
FRIDAY, Sept. 19 (HealthDay News) -- Regularly measuring fraction of exhaled nitric oxide (NO) didn't lead to improvement in asthma symptoms or lung function in young patients with asthma, according to research published in the Sept. 20 issue of The Lancet.
Abstract
Full Text (subscription or payment may be required)
Editorial
Several Risk Factors Linked to Adult-Onset Asthma
FRIDAY, Sept. 19 (HealthDay News) -- Factors associated with asthma diagnosed in adulthood include persistent wheezing in early life, bronchial hyper-responsiveness at 6 years of age, and allergic or non-allergic rhinitis in adulthood, according to the results of two studies published in the Sept. 20 issue of The Lancet.
Abstract - Stern
Full Text (subscription or payment may be required)
Abstract - Shaaban
Full Text (subscription or payment may be required)
Editorial
Antibiotic Resistance Has Become a Global Pandemic
FRIDAY, Sept. 19 (HealthDay News) -- A concerted international and national response, behavior change by consumers and providers, and the development of antibacterial agents are all urgently needed to tackle the global problem of rapidly increasing antibiotic resistance, according to an article published online Sept. 18 in BMJ.
Abstract
Full Text (subscription or payment may be required)
Maternal Vaccine Reduces Influenza in Infants
WEDNESDAY, Sept. 17 (HealthDay News) -- The use of influenza vaccine in pregnant women can decrease the risk of influenza in their infants up to six months of age and offer protection against febrile respiratory illness in both mothers and infants, according to research published online Sept. 17 in the New England Journal of Medicine.
Abstract
Full Text
MRI Improves Diagnosis in Children with Hearing Loss
WEDNESDAY, Sept. 17 (HealthDay News) -- An abnormal cochlea and abnormal cochlear nerve are the most common inner ear abnormalities in sensorineural hearing loss (SNHL), and inner ear abnormalities are more common among patients with severe and profound SNHL and in children with unilateral hearing loss, according to a report in the September issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Abstract
Full Text (subscription or payment may be required)
Assessment Tool Helps Predict Head and Neck Cancer Survival
WEDNESDAY, Sept. 17 (HealthDay News) -- In the first year after a head and neck cancer diagnosis, the trend for the subjective physical component of the 36-Item Short-Form Health Survey score is predictive of long-term cancer survival, according to a report in the September issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Abstract
Full Text (subscription or payment may be required)
Auricular Prostheses Help with Speech Recognition
MONDAY, Sept. 15 (HealthDay News) -- Auricular prostheses may offer users an acoustic gain, which in turn helps to improve speech recognition in noisy environments, according to research published in the September/October issue of the Archives of Facial Plastic Surgery.
Abstract
Full Text (subscription or payment may be required)
Drug Improves Survival in Head and Neck Cancer
WEDNESDAY, Sept. 10 (HealthDay News) -- The addition of cetuximab to platinum-based chemotherapy improves survival in patients with recurrent or metastatic head and neck cancer, according to a study in the Sept. 11 issue of the New England Journal of Medicine.
Abstract
Full Text (subscription or payment may be required)
Recommended Treatments Issued for Cerumen Impaction
WEDNESDAY, Sept. 3 (HealthDay News) -- Health care providers should treat symptomatic cerumen impactions or impactions that inhibit a clinical exam of the ear, according to the clinical practice guideline issued by the American Academy of Otolaryngology -- Head and Neck Surgery Foundation, published in the September issue of Otolaryngology -- Head and Neck Surgery.
Abstract
Full Text (subscription or payment may be required)
